Skip to content
Screener

Ginkgo Bioworks DNA Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$46.71M+22.5%-$76.06M+16.4%-$80.75M+24.9%-$80.76M-43.2%-$60.3M+72.2%
$12.32M-19.2%$12.8M-13.6%$13.66M-12.7%$15.26M-11.1%$15.25M-12.0%
$7.6M-59.6%$15.85M-8.8%$21.03M+2.3%$24.33M+75.6%$18.8M-49.4%
-$44.27M-10.0%-$46.69M+9.4%-$47.68M-12.4%-$31.61M+69.5%-$40.25M+52.3%
$2.62M+6,792%$1.93M-74.6%$5K-100.0%$0-100%$38K-99.9%
$11.09M+117%$23.13M+112%-$72.82M-614%-$63.89M-138%
$16.49M+16,926%-$19K+90.8%$8.14M+4,111%$9.94M+2,237%-$98K+56.6%
-$16.65M+84.0%-$23.7M+90.5%-$94.39M+17.3%-$104.05M+6.7%
-$46.89M-16.4%-$48.62M+17.8%-$47.68M+15.1%-$31.61M+73.3%-$40.29M+63.8%

FAQ

How much cash does Ginkgo Bioworks generate?
Ginkgo Bioworks (DNA) generated -$170.2M in operating cash flow over the trailing twelve months.
What is Ginkgo Bioworks's free cash flow?
After $4.6M of capital expenditures, Ginkgo Bioworks's free cash flow was -$174.8M over the trailing twelve months, up 36.2% year over year.
Where does Ginkgo Bioworks's cash flow data come from?
Every line is extracted from Ginkgo Bioworks's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.